Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)

Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) Prompts Immediate Treatment

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of potassium abnormalities.

Inclusion Criteria:

• Patients in emergency department.
• Patients recieved at least 1 ECG examination.

Exclusion Criteria:

• Patients recieved dyskalemia-related treatment before ECG examination.
• The patients recieved ECG at the period of inactive AI-ECG system.